A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Vemurafenib Impurity 1 | CAS 3430-21-5 - Request Quote

Picture of Vemurafenib Impurity 1

Vemurafenib Impurity 1

SZ CAT No:SZ-V058002
CAS No
3430-21-5
Mol.F.
C6H7BrN2
Mol.Wt.
187.0
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Vemurafenib Impurity 1 is chemically 5-Bromo-3-methylpyridin-2-amine. Vemurafenib Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Vemurafenib Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Vemurafenib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 3430-21-5

Purchase 3430-21-5

Order 3430-21-5

Enquire 3430-21-5

price of 3430-21-5

3430-21-5 Supplier

3430-21-5 Manufacturer

3430-21-5 Exporter

buy high quality Vemurafenib Impurity 1

Purchase Vemurafenib Impurity 1

Vemurafenib Impurity 1 suppliers

Vemurafenib Impurity 1 manufacturers

Vemurafenib Impurity 1 price

Order Vemurafenib Impurity 1

Enquire Vemurafenib Impurity 1

Vemurafenib Impurity 1 cost

Vemurafenib Impurity 1 Supplier

Vemurafenib Impurity 1 Distributor

Vemurafenib Impurity 1 for Method Validation

Vemurafenib Reference Standard

Vemurafenib Impurity 1 for ANDA Filing

Vemurafenib Impurity 1 for Forced Degradation Studies

Vemurafenib Impurity 1 Identification Standards

Vemurafenib Impurity 1 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,